首页> 外国专利> REPLICONS OF PESTIVIRUSES THAT DO NOT EXPRESS C AND OR E1 PROTEIN AND INFECTIOUS VIRAL PARTICLES CONTAINING SAME, THAT CAN BE USED IN VACCINES

REPLICONS OF PESTIVIRUSES THAT DO NOT EXPRESS C AND OR E1 PROTEIN AND INFECTIOUS VIRAL PARTICLES CONTAINING SAME, THAT CAN BE USED IN VACCINES

机译:不表达C和/或E1蛋白和包含相同病毒的感染性病毒颗粒的瘟疫病毒复制品

摘要

The present invention provides new Pestiviral RNA genomes (replicons) that areable to replicate, and can be packaged into infectious viral particles incells that complement the missing protein(s), but do not produce infectiousprogeny virus. Such replicons can be useful for vaccine purposes. Thereplicons encode most, preferably all, envelop proteins of the virus, while,on the other hand, it would not be capable of producing infectious progenyvirus. The present invention provides a Pestiviral replicon, preferably fromthe Bovine Viral Diarrhea Virus (BVDV), which expresses all structuralproteins except for a functional C or E1 protein. Preferably at least part ofthe coding sequence of the E1 or C protein has been deleted from saidreplicon. The present inventors proved for the first time, that both C and E1structural proteins are essential for the formation of infectiouspestiviruses. Furthermore it was shown that deletion of C and E1 does notimpact the ability of RNA self-replication. By using cell lines constitutivelyexpressing pestiviral structural proteins, Capsid- or E1-proteins can beefficiently trans-complemented. The resulting virions are able to infectbovine target cells and to transfer the replicons without generatingreplication-competent virus progeny. In other words, no infectious progenyvirus is produced. The complemented virions are indistinguishable from wild-type Pestivirus.in virus neutralization experiments. Recombinations yieldinginfectious wild-type virus were not detected in any of the complementationexperiments. The complemented viruses may be used for the safe and efficaciousimmunization against BVDV.
机译:本发明提供了新的瘟病毒RNA基因组(复制子),其是能够复制,并可以包装成传染性病毒颗粒补充缺失蛋白质但不产生传染性的细胞后代病毒。这样的复制子可用于疫苗目的。的复制子编码病毒的大部分(最好是全部)包膜蛋白,而另一方面,它将无法产生传染性子代病毒。本发明提供了瘟病毒复制子,优选来自牛病毒性腹泻病毒(BVDV),它表达所有结构除功能性C或E1蛋白外的其他蛋白。优选至少一部分E1或C蛋白的编码序列已从该序列中删除复制子。本发明人首次证明了C和E1结构蛋白对于形成传染性至关重要瘟病毒。此外,还表明删除C和E1不会影响RNA自我复制的能力。通过组成性使用细胞系表达瘟病毒结构蛋白的衣壳蛋白或E1蛋白可以是有效地进行反补充。产生的病毒粒子能够感染牛靶细胞并转移复制子而不产生具有复制能力的病毒后代。换句话说,没有传染性后代产生了病毒。互补的病毒粒子与野生的在病毒中和实验中输入Pestivirus。重组产生在任何互补中均未检测到传染性野生型病毒实验。补充的病毒可用于安全有效针对BVDV的免疫。

著录项

  • 公开/公告号CA2495294C

    专利类型

  • 公开/公告日2012-06-12

    原文格式PDF

  • 申请/专利权人 AKZO NOBEL N.V.;

    申请/专利号CA20032495294

  • 发明设计人 BEER MARTIN;REIMANN ILONA;

    申请日2003-08-12

  • 分类号C12N15/86;A61K39/12;C07K14/18;C12N5/10;C12N7/04;

  • 国家 CA

  • 入库时间 2022-08-21 17:20:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号